Conjugated oestrogens with medroxyprogesterone - Menopausal disorders
You are here : Home > Formulary Search > Conjugated oestrogens with medroxyprogesterone - Menopausal disorders
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Modified release tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
Premique Low Dose - no longer recommended. Switch to a newer, lower risk formulation.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Conjugated oestrogens with medroxyprogesterone
Indication :
Menopausal disorders
Group Name :
Keywords :
hormone replacement therapy, HRT, menopause, continuous combined therapy, menopausal symptoms
Brand Names Include :
Premique Low Dose
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Conjugated oestrogens with medroxyprogesterone is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Menopausal disorders.
- Clonidine hydrochloride
- Conjugated oestrogens
- Drospirenone
- Estradiol
- Estradiol with dydrogesterone
- Estradiol with levonorgestrel
- Estradiol with medroxyprogesterone
- Estradiol with norethisterone
- Estradiol with progesterone
- Ethinylestradiol
- Gabapentin
- Levonorgestrel
- Medroxyprogesterone acetate
- Paroxetine
- Pregabalin
- Progesterone
- St Johns Wort
- Tibolone
- Venlafaxine
Committee Recommendations (1)
The Surrey Heartlands APC has agreed a traffic light status and place in therapy for the treatments of menopausal disorders in line with the CKS recommenations: